Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 3, 2004, Pages 360-364

  Powell, Ami M ^a   Albert, S ^a   Oyama, N ^a   Sakuma Oyama, Y ^a   Bhogal, B ^a   Black, M M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Fludarabine; Mycophenolate mofetil; Paraneoplastic pemphigus; Pemphigus vegetans

Indexed keywords

ACICLOVIR; AUTOANTIBODY; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DESMOGLEIN 1; DESMOGLEIN 2; FLUCONAZOLE; FLUDARABINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

AGED; ANTIBODY TITER; ARTICLE; BLADDER; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; IMMUNOFLUORESCENCE; LIP DISEASE; LOW DRUG DOSE; MALE; MOUTH DISEASE; MOUTH LESION; MUCOSA INFLAMMATION; PARANEOPLASTIC SYNDROME; PEMPHIGUS; PNEUMONIA; PRIORITY JOURNAL; REMISSION; SEPTICEMIA; SKIN DEFECT;

AGED; BIOPSY, NEEDLE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MYCOPHENOLIC ACID; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STOMATITIS; TREATMENT OUTCOME; VIDARABINE;

EID: 2442610919     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00917.x     Document Type: Article

References (20)

1. Anhalt GJ, Kim SC, Stanley JR et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-1735.
2. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol 1997; 12: 77-96.
3. Ohyama M, Amagai M, Hashimoto T et al. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus. J Am Acad Dermatol 2001; 44: 593-598.
4. Nguyen VT, Ndoye A, Bassler KD et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001; 137: 193-206.
5. Leung CL, Green KJ, Liem RKH. Plakins: a family of versatile cytolinker proteins. Trends Cell Biol 2002; 12: 37-45.
6. Nousari HC, Deterding R, Wojtczack H et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999; 340: 1406-1410.
7. Komai A, Amagai M, Ishii K et al. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay. Br J Dermatol 2001; 144: 1177-1182.
8. Storwick GS, Prihoda MB, Fulton RJ, Wood WS. Pyodermatitis-pyostomatitis vegetans: a specific marker for inflammatory bowel disease. J Am Acad Dermatol 1994; 31: 336-341.
9. Sapadin AN, Anhalt GJ. Paraneoplastic pemphigus with a pemphigus vegetans-like plaque as the only cutaneous manifestation. J Am Acad Dermatol 1998; 39: 867-871.
10. Kipps TJ, Carson DA. Autoantibodies in chronic lymphocytic leukaemia and related systemic autoimmune disease. Blood 1993; 81: 2475-2487.
11. Anhalt GJ. Paraneoplastic pemphigus: the role of tumours and drugs. Br J Dermatol 2001; 144: 1102-1104.
12. Van Den Neste E, Delannoy A et al. Second primary tumours and immune phenomena after fludarabine or 2-chloro-2′deoxyadenosine. Leuk Lymph 2001; 40: 541-550.
13. Bazarbachi A, Bachelez H, Dehen L et al. Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine. Ann Oncol 1995; 6: 730-731.
14. Gooptu C, Littlewood TJ, Frith P et al. Paraneoplastic pemphigus: an association with fludarabine? Br J Dermatol 2001; 144: 1255-1261.
15. Reich K, Brinck U, Letshert M et al. Graft-versus-host disease like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus. Br J Dermatol 1999; 141: 739-746.
16. Hsiao CJ, Hsu MM, Lee JY et al. Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides-like eruption. A case report and review of literature. Br J Dermatol 2001; 144: 372-376.
17. Williams JV, Marks JG Jr, Billingsley EM. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol 2000; 142: 506-508.
18. Tressler RJ, Garvin LJ, Slate DL. Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo. Int J Cancer 1994; 57: 568-573.
19. Brewin TB, Cole MP, Jones CT et al. Mycophenolic acid (NSC-129185): preliminary clinical trials. Cancer Chemother Rep 1972; (Pt 1) 56: 83-87.
20. Bowen GM, Peters NT, Fivenson DP et al. Lichenoid dermatitis in paraneoplastic pemphigus. Arch Dermatol 2000; 136: 652-656.